# FDA Inspection 1187512 - StemCure,  Inc. - November 07, 2022

Source: https://www.keypedia.com/records/fda_inspections/stemcure-inc/ccf25990-523b-4e9f-9f0a-24aab373d8a0
Source feed: FDA_Inspections

> FDA Inspection 1187512 for StemCure,  Inc. on November 07, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1187512
- Company Name: StemCure,  Inc.
- Inspection Date: 2022-11-07
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1187512 - 2022-11-07](https://www.keypedia.com/records/fda_inspections/stemcure-inc/608a8d2a-d830-4f3e-aca4-c36be3994dce)
- [FDA Inspection 1187512 - 2022-11-07](https://www.keypedia.com/records/fda_inspections/stemcure-inc/86db86ed-c771-4cbc-a96e-ab26d106da37)
- [FDA Inspection 1052724 - 2018-05-08](https://www.keypedia.com/records/fda_inspections/stemcure-inc/d2cfa960-6055-4132-847d-1c73d0ef4352)
- [FDA Inspection 953354 - 2015-12-03](https://www.keypedia.com/records/fda_inspections/stemcure-inc/868d0f66-21a3-44ff-8590-299612aa1db6)

Company: https://www.keypedia.com/companies/stemcure-inc/7b6ef27b-1bb9-44bc-b610-4a66a001d7a8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d